Nasopharyngeal Cancer
Research from the United States, People's Republic of China and Taiwan add new data to nasopharyngeal cancer body of knowledge
Published in Hospital Business Week, November 26th, 2006
Study 1: Tumor control in patients with locally advanced nasopharyngeal carcinoma (NPC) could be improved with concurrent chemoradiotherapy (CRT) and accelerated fractionation (AF) when compared to conventional radiotherapy (RT) alone.
Researchers in the People's Republic of China conducted a study "to compare the benefit achieved by concurrent CRT and/or AF vs. radiotherapy (RT) alone with conventional fractionation (CF) for patients with T3-4N0-1M0 NPC. All patients were irradiated with the same RT technique to {{>=}}66 Gy at 2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Antibacterial Agents
Pneumonia germ cell wall can damage heart, brain cells - Antibacterial Agents
U.S. Food and Drug Administration issues non-approvable letter to Replidyne for faropenem - Asthma
Sepracor presents data for two forms of Xopenex (levalbuterol) - Awards
Grant will educate physicians and medical students about pharmaceutical company marketing practices - Awards
Highmark Foundation awards grants to support cancer, bird flu and patient care programs - Awards
Packard Children's Hospital receives honor from quality and safety group - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
